Analyst Ratings for Corcept Therapeutics (cort)

cort Rating Summary

cort Price Target Summary

* Over Last 12-Mos
  |   Expand Research on cort
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $8.50 (+52.3%) * Over Last 12-Mos
Rating Score: 5 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
3/11/2015 Piper Jaffray Upgrade Overweight
(Neutral)
9.00
(2.50)
3.37 5.58 65.58% Details
4/1/2014 Brinson Patrick New Coverage Market Outperform
(N/A)
8.00
(N/A)
4.36 5.58 27.98% Details